Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SciFluor Life Sciences, an Allied Minds-funded company with a late-stage fluorination technology that improves drug properties such as metabolic stability, potency, bioavailability and blood-brain barrier penetration, has named Arthur Hiller as the new CEO.
Subscribe to our email newsletter
Most recently, Hiller has served as the CEO of venture-backed cardiovascular device start-up Heartscape Technologies.
Prior to that he worked as the senior vice president at Millennium Pharmaceuticals.
Hiller said the patented SciFluor technology offers companies a solution to the challenge of fluorination that has the potential to significantly accelerate and improve the drug discovery and development process.
"The platform also gives SciFluor an opportunity to identify fluorinated versions of currently marketed products that may support partnerships with drug companies and ultimately offer physicians and their patients new and enhanced treatment options," Hiller said.